-
2023-510433-29-00
5
2020-09-24
Favorable-intermediate-risk Acute Myeloid Leukemia
-
2023-505901-17-00
5
2020-04-24
Acute Myeloid Leukemia (LMA) with FLT3 mutation
-
2023-510516-39-00
4
2019-10-30
Acute B-cell Lymphoblastic Leukemia with minimal residual positive dis
-
2024-513372-18-00
4
2019-10-18
Pre- and post-menopausal women with HR+/HER2- LABC or MBC whose diseas
-
2024-513968-25-00
5
2025-04-28
Metastatic castration-resistant prostate cancer (mCRPC)
-
2024-512180-31-00
4
2025-03-14
Oligometastatic renal cell carcinoma
-
2022-501457-37-00
5
2024-10-28
Myeloid Leukemia in Children with Down Syndrome
-
2024-511627-34-00
4
2024-10-17
Very High-Risk T-Lineage Acute Lymphoblastic Leukemia (ALL)
-
2022-501176-26-00
5
2023-08-04
Acute Ischemic Stroke and High-Risk Transient Ischemic Attack
-
2024-512568-72-00
5
2023-02-24
BCG-unresponsive Carcinoma in Situ of the bladder with or without Ta-T
-
2023-508740-21-00
4
2023-02-15
Non-Small Cell Lung Cancer
-
2022-500861-29-00
5
2023-01-12
Relapsed or Refractory Multiple Myeloma (RRMM)
-
2024-515557-22-00
6
2022-10-01
Juvenile Idiopathic Arthritis
-
2023-503640-14-00
5
2022-02-17
Newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphobla
-
2023-508968-30-00
5
2021-09-08
Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
-
2024-518847-40-00
4
2021-07-16
recurrent ovarian cancer
-
2023-504684-16-00
5
2021-06-05
follicular lymphoma (FL) and marginal zone lymphoma (MZL)
-
2024-516868-28-00
4
2021-05-04
Ph+ Acute Lymphoblastic Leukemia
-
2022-500237-92-00
5
2021-04-23
Newly-diagnosed high-intermediate and high-risk diffuse large B-cell l
-
2023-507263-19-00
5
2020-12-23
Advanced Non-Small Cell Lung Cancer
-
2023-503591-25-00
5
2020-06-09
Non-small cell lung cancer
-
2023-508463-71-00
5
2018-11-30
Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic L
-
2023-509856-32-00
5
2018-07-15
acute lymphoblastic leukemia in children and adolescents
-
2023-510434-83-00
6
2016-10-17
Chronic Myeloid Leukemia (CML) in Chronic Phase (CP)